1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MYOF CTRPv2 pan-cancer AAC -0.26 5e-12
mRNA ANXA5 CTRPv2 pan-cancer AAC -0.24 6e-08
mRNA RTFDC1 CTRPv2 pan-cancer AAC -0.23 3e-11
mRNA TNFRSF12A CTRPv2 pan-cancer AAC -0.22 4e-08
mRNA LTBR CTRPv2 pan-cancer AAC -0.21 2e-07
mRNA RNF181 CTRPv2 pan-cancer AAC -0.21 1e-10
mRNA TPD52L2 CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA MANBAL CTRPv2 pan-cancer AAC -0.21 8e-07
mRNA MCFD2 CTRPv2 pan-cancer AAC -0.21 2e-09
mRNA FAM209A CTRPv2 pan-cancer AAC -0.2 2e-09
Download CSV